The usefulness of patch testing on the previously most severely affected site in a cutaneous adverse drug reaction to tetrazepam

Contact Dermatitis

Volumn 44, Issue 4, 2001, Pages 246-263

  Barbaud, A ^a   Trechot, P ^a   Reichert Penetrat, S ^a   Granel, F ^a   Schmutz, J L ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

Benzodiazepines; Cutaneous adverse drug reactions; Lack of cross sensitivity; Maculopapular rash; Medicaments; Positive patch test; Tetrazepam

Indexed keywords

BROMAZEPAM; CLORAZEPATE DIPOTASSIUM; DIAZEPAM; PANOS; TETRAZEPAM;

ADULT; ARTICLE; BINDING SITE; CASE REPORT; DIAGNOSTIC VALUE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; PATCH TEST; RASH;

EID: 0035081816     PISSN: 01051873     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0536.2001.440409-15.x     Document Type: Article

References (12)

1. Adverse drug reaction monitoring: Doing it the French way
2. The use of skin testing in the investigation of cutaneous adverse drug reactions
3. Tests cutanés dans l'exploration des toxidermies supposees de mecanisme immuno-allergique
4. Topical provocation of fixed drug eruption
5. Tetrazepam allergy detected by patch tests
6. Tetrazepam allergy once more detected by patch test
7. Allergic skin reaction to tetrazepam detected by patch testing
8. Delayed cell-mediated hypersensitivity to tetrazepam
9. Topical provocation of fixed drug eruption: A study of 30 patients
10. Patch testing in an unusual case of toxic epidermal necrolysis
11. Immunological physiopathology of cutaneous adverse drug reactions
12. Fixed drug eruption: An immunohistochemical investigation of the acute and healing phase